The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Effect of Isoniazid on the In Vivo Mycolic Acid Synthesis, Cell Growth, and Viability of Mycobacterium tuberculosis
Open accessAbstract
When an actively growing culture of the H37Ra strain of Mycobacterium tuberculosis was exposed to isoniazid at a concentration of 0.5 μg/ml, the cells began to lose their ability to synthesize mycolic acids immediately. After 60 min, the cells had completely lost this ability. The synthesis of the three mycolate components—α-mycolate, methoxymycolate, and β-mycolate—was inhibited. The viability of the isoniazid-treated cells was unaffected up to about 60 min of exposure, after which time there was a gradual decline in the viability to about 18% after 180 min. Correspondingly, growth of the drug-treated cells slowed down and stopped after 24 hr. The inhibition of the synthesis of mycolic acids was reversible if the drug was removed before the loss of viability set in. Incubation of the viable cells in the absence of the drug for 24 hr restored the mycolate synthesis. These results strongly suggest that the inhibition of the synthesis of the mycolic acids is closely associated with the primary mechanism of action of isoniazid on the tubercle bacilli. The sequence of events which leads to the loss of viability of cells exposed to isoniazid is described.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition by Isoniazid of Synthesis of Mycolic Acids in Mycobacterium tuberculosis
Winder, F. G., & Collins, P. B. (1970) · Journal of General Microbiology · doi:10.1099/00221287-63-1-41 · Cited by 252
Enzymatic Synthesis of Cyclopropane Fatty Acids Catalyzed by Bacterial Extracts
Zalkin, H., Law, J. H., & Goldfine, H. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81170-x · Cited by 117
Middlebrook, G. (1952) · PubMed · Cited by 100
Takayama, K., & Goldman, D. S. (1970) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)62601-8 · Cited by 75
Self-citationIn vitro studies on isonicotinic acid hydrazide.
PANSY, F. E., Stander, H. J., & Donovick, R. (1952) · PubMed · Cited by 42
Fethke, N., & Anderson, R. J. (1948) · PubMed · doi:10.1164/art.1948.57.3.294 · Cited by 8
Cited by
inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosis
Banerjee, A., Dubnau, E., Quemard, A., Balasubramanian, V., Um, K. S., Wilson, T., Collins, D., de Lisle, G., & Jacobs, W. R. (1994) · Science · doi:10.1126/science.8284673 · Cited by 1,389
Wayne, L. G., & Hayes, L. G. (1996) · Infection and Immunity · doi:10.1128/iai.64.6.2062-2069.1996 · Cited by 1,141
Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis
Mahairas, G. G., Sabo, P. J., Hickey, M. J., Singh, D. C., & Stover, C. K. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.5.1274-1282.1996 · Cited by 1,103
Nonreplicating Persistence of Mycobacterium Tuberculosis
Wayne, L. G., & Sohaskey, C. D. (2001) · Annual Review of Microbiology · doi:10.1146/annurev.micro.55.1.139 · Cited by 807
Modification of the NADH of the Isoniazid Target (InhA) from Mycobacterium tuberculosis
Rozwarski, D. A., Grant, G. A., Barton, D. H. R., Jacobs, W. R., & Sacchettini, J. C. (1998) · Science · doi:10.1126/science.279.5347.98 · Cited by 682
Mycolic Acids: Structures, Biosynthesis, and Beyond
Marrakchi, H., Lanéelle, M.-A., & Daffé, M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.11.011 · Cited by 623
Antimicrobial agent resistance in mycobacteria: molecular genetic insights
Musser, J. M. (1995) · Clinical Microbiology Reviews · doi:10.1128/cmr.8.4.496 · Cited by 621
Mycolic acids: structure, biosynthesis and physiological functions
Barry, C. E., Lee, R. E., Mdluli, K., Sampson, A. E., Schroeder, B. G., Slayden, R. A., & Yuan, Y. (1998) · Progress in Lipid Research · doi:10.1016/s0163-7827(98)00008-3 · Cited by 565
Wilson, M., DeRisi, J., Kristensen, H.-H., Imboden, P., Rane, S., Brown, P. O., & Schoolnik, G. K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12833 · Cited by 547
Tahlan, K., Wilson, R., Kastrinsky, D. B., Arora, K., Nair, V., Fischer, E., Barnes, S. W., Walker, J. R., Alland, D., Barry, C. E., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05708-11 · Cited by 504
Compensatory ahp C Gene Expression in Isoniazid-Resistant Mycobacterium tuberculosis
Sherman, D. R., Mdluli, K., Hickey, M. J., Arain, T. M., Morris, S. L., Barry, C. E., & Stover, C. K. (1996) · Science · doi:10.1126/science.272.5268.1641 · Cited by 436
Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosis
Dessen, A., Quémard, A., Blanchard, J. S., Jacobs, W. R., & Sacchettini, J. C. (1995) · Science · doi:10.1126/science.7886450 · Cited by 430
Mechanisms of action of isoniazid
Timmins, G. S., & Deretic, V. (2006) · Molecular Microbiology · doi:10.1111/j.1365-2958.2006.05467.x · Cited by 421
Why do bacteria use so many enzymes to scavenge hydrogen peroxide?
Mishra, S., & Imlay, J. (2012) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2012.04.014 · Cited by 411
Inhibition of a Mycobacterium tuberculosis β-Ketoacyl ACP Synthase by Isoniazid
Mdluli, K., Slayden, R. A., Zhu, Y., Ramaswamy, S., Pan, X., Mead, D., Crane, D. D., Musser, J. M., & Barry, C. E. (1998) · Science · doi:10.1126/science.280.5369.1607 · Cited by 398
Portevin, D., de Sousa-D'Auria, C., Houssin, C., Grimaldi, C., Chami, M., Daffé, M., & Guilhot, C. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305439101 · Cited by 390
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Heym, B., Philipp, W., & Cole, S. T. (1996) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-80166-2_3 · Cited by 379
Enzymic Characterization of the Target for Isoniazid in Mycobacterium tuberculosis
Quemard, A., Sacchettini, J. C., Dessen, A., Vilcheze, C., Bittman, R., Jacobs, W. R., & Blanchard, J. S. (1995) · Biochemistry · doi:10.1021/bi00026a004 · Cited by 373
Lipid biosynthesis as a target for antibacterial agents
Heath, R. J., White, S. W., & Rock, C. O. (2001) · Progress in Lipid Research · doi:10.1016/s0163-7827(01)00012-1 · Cited by 344
The Mechanism of Isoniazid Killing: Clarity Through the Scope of Genetics
Vilchèze, C., & Jacobs, Jr. (2007) · Annual Review of Microbiology · doi:10.1146/annurev.micro.61.111606.122346 · Cited by 335
Transfer of a point mutation in Mycobacterium tuberculosis inhA resolves the target of isoniazid
Vilchèze, C., Wang, F., Arai, M., Hazbón, M. H., Colangeli, R., Kremer, L., Weisbrod, T. R., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2006) · Nature Medicine · doi:10.1038/nm1466 · Cited by 319
Activation of the Pro-drug Ethionamide Is Regulated in Mycobacteria
Baulard, A. R., Betts, J. C., Engohang-Ndong, J., Quan, S., McAdam, R. A., Brennan, P. J., Locht, C., & Besra, G. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003744200 · Cited by 311
Mechanism of thioamide drug action against tuberculosis and leprosy
Wang, F., Langley, R., Gulten, G., Dover, L. G., Besra, G. S., Jacobs, W. R., & Sacchettini, J. C. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20062100 · Cited by 303
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
Unissa, A. N., Subbian, S., Hanna, L. E., & Selvakumar, N. (2016) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2016.09.004 · Cited by 300
Rozwarski, D. A., Vilchèze, C., Sugantino, M., Bittman, R., & Sacchettini, J. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.22.15582 · Cited by 290
Vilchèze, C., & Jacobs JR., W. R. (2014) · Microbiology Spectrum · doi:10.1128/microbiolspec.mgm2-0014-2013 · Cited by 289
ethA , inhA , and katG Loci of Ethionamide-Resistant Clinical Mycobacterium tuberculosis Isolates
Morlock, G. P., Metchock, B., Sikes, D., Crawford, J. T., & Cooksey, R. C. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.12.3799-3805.2003 · Cited by 288
Altered NADH/NAD + Ratio Mediates Coresistance to Isoniazid and Ethionamide in Mycobacteria
Vilchèze, C., Weisbrod, T. R., Chen, B., Kremer, L., Hazbón, M. H., Wang, F., Alland, D., Sacchettini, J. C., & Jacobs, W. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.708-720.2005 · Cited by 284
Vilchèze, C., Morbidoni, H. R., Weisbrod, T. R., Iwamoto, H., Kuo, M., Sacchettini, J. C., & Jacobs, W. R. (2000) · Journal of Bacteriology · doi:10.1128/jb.182.14.4059-4067.2000 · Cited by 283
Mechanisms of Drug Resistance in Mycobacterium tuberculosis
Zhang, Y., Vilchèze, C., & Jacobs, W. R. (2004) · Tuberculosis and the Tubercle Bacillus · doi:10.1128/9781555817657.ch8 · Cited by 261
Miesel, L., Weisbrod, T. R., Marcinkeviciene, J. A., Bittman, R., & Jacobs, W. R. (1998) · Journal of Bacteriology · doi:10.1128/jb.180.9.2459-2467.1998 · Cited by 155
Metadata
- Authors
- Takayama, K., Wang, L., & David, H. L.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 1972-07
- Volume
- 2
- Issue
- 1
- Pages
- 29-35
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2027340405
- Cited by
- 292
- References
- 6
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.